The DOI matches its Crossref record.
Trends in the presentation, treatment, and survival of patients with medullary thyroid cancer over the past 30 years
Open accessAbstract
Background. The impact of recent medical advances on disease presentation, extent of operation, and disease‐specific survival for patients with medullary thyroid cancer is unclear. Methods. We used the Surveillance, Epidemiology, and End Results registry to compare trends over 3 time periods, 1983–1992, 1993–2002, and 2003–2012. Results. There were 2,940 patients diagnosed with medullary thyroid cancer between 1983 and 2012. The incidence of medullary thyroid cancer increased during this time period from 0.14 to 0.21 per 100,000 population, and mean age at diagnosis increased from 49.8 to 53.8 (P < .001). The proportion of tumors ≤1 cm also increased from 11.4% in 1983–1992, 19.6% in 1993–2002, to 25.1% in 2003–2012 (P < .001), but stage at diagnosis remained constant (P = .57). In addition, the proportion of patients undergoing a total thyroidectomy and lymph node dissection increased from 58.2% to 76.5% during the study period (P < .001). In the most recent time interval, 5‐year, disease‐specific survival improved from 86% to 89% in all patients (P < .001) but especially for patients with regional (82% to 91%, P = .003) and distant (40% to 51%, P = .02) disease. Conclusion. These data demonstrate that the extent of operation is increasing for patients with medullary thyroid cancer. Disease‐specific survival is also improving, primarily in patients with regional and distant disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Patel, K. N., Yip, L., Lubitz, C. C., Grubbs, E. G., Miller, B. S., Shen, W., Angelos, P., Chen, H., Doherty, G. M., Fahey, T. J., et al. (2020) · Annals of Surgery · doi:10.1097/sla.0000000000003580 · Cited by 541
A phase I/II study of rovalpituzumab tesirine in delta-like 3—expressing advanced solid tumors
Mansfield, A. S., Hong, D. S., Hann, C. L., Farago, A. F., Beltran, H., Waqar, S. N., Hendifar, A. E., Anthony, L. B., Taylor, M. H., Bryce, A. H., et al. (2021) · npj Precision Oncology · doi:10.1038/s41698-021-00214-y · Cited by 80
Metadata
- Authors
- Randle, R. W., Balentine, C. J., Leverson, G. E., Havlena, J. A., Sippel, R. S., Schneider, D. F., & Pitt, S. C.
- Venue
- Surgery
- Publisher
- Elsevier BV
- Published
- 2017-01
- Volume
- 161
- Issue
- 1
- Pages
- 137-146
- ISSN
- 0039-6060 (ISSN-L)
- OpenAlex
- W2552283786
- Cited by
- 221
- References
- 0
- FWCI
- 12.99
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Trends in the presentation, treatment, and survival of patients with medullary thyroid cancer over the past 30 years. https://app.cochat.ai/papers/10.1016/j.surg.2016.04.053
- The paper
- Randle, R. W., Balentine, C. J., Leverson, G. E., Havlena, J. A., Sippel, R. S., Schneider, D. F., & Pitt, S. C. (2017). Trends in the presentation, treatment, and survival of patients with medullary thyroid cancer over the past 30 years. Surgery. https://doi.org/10.1016/j.surg.2016.04.053
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.